1.1 Buyer
Official name
:
University clinic of radiotherapy and oncology
Medicines for biological therapy
Medicines for biological therapy Ljekovi za biolosku terapiju L01FE01 Cetuximab solution for infusion 5 mg/mlx20 ml L01FE01 Cetuximab otopina za infuziju 5 mg/mlx20 ml L01FF02 Pembrolizumab powder for concentrate for solution for infusion 25mg/mlx4ml L01FF02 Pembrolizumab prašak za koncentrat za otopinu za infuziju 25mg/mlx4ml L01BA04 Pemetrexed powder for concentrate for …
CPV: 33600000 Productos farmacéuticos
1. Buyer
2. Procedure
2.1 Procedure
Title
:
Medicines for biological therapy
Description
:
Medicines for biological therapy
Procedure identifier
:
2e05d83e-0395-457d-9de4-b2ad437223a5
Type of procedure
:
Open
Main features of the procedure
:
Еverything is described in the tender documentation
2.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
2.1.2 Place of performance
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
2.1.4 General information
Additional information
:
Еverything is described in the tender documentation
Legal basis
:
Directive 2014/24/EU
5. Lot
5.1 Lot technical ID : LOT-0001
Title
:
L01FE01 Cetuximab
Description
:
L01FE01 Cetuximab solution for infusion 5 mg/mlx20 ml
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0002
Title
:
L01FF02 Pembrolizumab
Description
:
L01FF02 Pembrolizumab powder for concentrate for solution for infusion 25mg/mlx4ml
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0003
Title
:
L01BA04 Pemetrexed
Description
:
L01BA04 Pemetrexed powder for concentrate for solution for infusion / concentrate for solution for infusion 500 mg
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0004
Title
:
L01FD03 Trastuzumab
Description
:
L01FD03 Trastuzumab emtansine powder for concentrate for solution for infusion 100 mg/15 ml
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0005
Title
:
L01FD03 Trastuzumab
Description
:
L01FD03 Trastuzumab emtansine powder for concentrate for solution for infusion 160 mg/20 ml
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0006
Title
:
L01XY02 Pertuzumab/trastuzumab
Description
:
L01XY02 Pertuzumab/trastuzumab solution for subcutaneous injection; 600 mg pertuzumab, 600 mg trastuzumab /10 mL solution in vial 600mg/600 mg
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0007
Title
:
L01FF01 Nivolumab
Description
:
L01FF01 Nivolumab concentrate for infusion 40 mg
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0008
Title
:
L01FF01 Nivolumab
Description
:
L01FF01 Nivolumab concentrate for infusion 100 mg
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
5.1 Lot technical ID : LOT-0009
Title
:
L01XE33 Palbociclib
Description
:
L01XE33 Palbociclib capsule, hard 125 mg tablet
5.1.1 Purpose
Main nature of the contract
:
Supplies
Main classification
(
cpv
):
33600000
Pharmaceutical products
5.1.2 Place of performance
Postal address
:
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Additional information
:
5.1.6 General information
Reserved participation
:
Participation is not reserved.
Procurement Project not financed with EU Funds.
5.1.11 Procurement documents
Languages in which the procurement documents are officially available
:
Macedonian
Languages in which the procurement documents (or their parts) are unofficially available
:
Macedonian
5.1.12 Terms of procurement
Terms of submission
:
Languages in which tenders or requests to participate may be submitted
:
Macedonian
Deadline for receipt of tenders
:
29/11/2024
10:00 +01:00
Information about public opening
:
Opening date
:
29/11/2024
10:00 +01:00
Terms of contract
:
The execution of the contract must be performed within the framework of sheltered
employment programmes
:
No
5.1.16 Further information, mediation and review
Mediation organisation
:
University clinic of radiotherapy and oncology
Review organisation
:
University clinic of radiotherapy and oncology
Organisation providing additional information about the procurement procedure
:
University clinic of radiotherapy and oncology
Organisation providing offline access to the procurement documents
:
University clinic of radiotherapy and oncology
Organisation providing more information on the review procedures
:
University clinic of radiotherapy and oncology
Organisation receiving requests to participate
:
University clinic of radiotherapy and oncology
Organisation processing tenders
:
University clinic of radiotherapy and oncology
TED eSender
:
Publications Office of the European Union
8. Organisations
8.1 ORG-0001
Official name
:
University clinic of radiotherapy and oncology
Registration number
:
6259936
Postal address
:
Majka Tereza 17
1000
Town
:
Skopje
Postcode
:
1000
Country subdivision (NUTS)
:
Скопски
(
MK008
)
Country
:
North Macedonia
Contact point
:
University clinic of radiotherapy and oncology
Telephone
:
+38923147874
Fax
:
+38923147874
Roles of this organisation
:
Buyer
Organisation providing additional information about the procurement procedure
Organisation providing offline access to the procurement documents
Organisation receiving requests to participate
Organisation processing tenders
Review organisation
Organisation providing more information on the review procedures
Mediation organisation
8.1 ORG-0000
Official name
:
Publications Office of the European Union
Registration number
:
PUBL
Town
:
Luxembourg
Postcode
:
2417
Country subdivision (NUTS)
:
Luxembourg
(
LU000
)
Country
:
Luxembourg
Telephone
:
+352 29291
Roles of this organisation
:
TED eSender
11. Notice information
11.1 Notice information
Notice identifier/version
:
d44716e4-e4dd-4eac-8659-e0036a0750d1
-
01
Form type
:
Competition
Notice type
:
Contract notice – light regime
Notice dispatch date
:
08/11/2024
19:29 +00:00
Languages in which this notice is officially available
:
English
Croatian
11.2 Publication information
Notice publication number
:
00686542-2024
OJ S issue number
:
220/2024
Publication date
:
12/11/2024